ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,183,809 | -28.8% | 1,126,915 | 0.0% | 0.38% | -32.0% |
Q2 2023 | $7,279,871 | -14.3% | 1,126,915 | 0.0% | 0.56% | +0.4% |
Q1 2023 | $8,496,939 | -25.6% | 1,126,915 | 0.0% | 0.56% | -21.3% |
Q4 2022 | $11,415,649 | +2.4% | 1,126,915 | 0.0% | 0.71% | +34.3% |
Q3 2022 | $11,145,000 | -7.1% | 1,126,915 | 0.0% | 0.53% | -10.2% |
Q2 2022 | $12,002,000 | +29.2% | 1,126,915 | +166.8% | 0.59% | +43.4% |
Q2 2021 | $9,292,000 | – | 422,382 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |